Two sources told Reuters that about 20 employees from the FDA’s office of neurological and physical medicine devices, some involved with Neuralink-related matters, were among those let go. However, the sources did not believe the employees were…
Two sources told Reuters that about 20 employees from the FDA’s office of neurological and physical medicine devices, some involved with Neuralink-related matters, were among those let go. However, the sources did not believe the employees were…